Karen Wozniak to Candida albicans
This is a "connection" page, showing publications Karen Wozniak has written about Candida albicans.
Connection Strength
0.672
-
Non-Antibiotic Antimony-Based Antimicrobials. Molecules. 2022 Oct 23; 27(21).
Score: 0.203
-
Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun. 2002 Oct; 70(10):5790-9.
Score: 0.203
-
Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37. Med Mycol. 2010 Mar; 48(2):263-72.
Score: 0.085
-
The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivo. Infect Immun. 2005 Nov; 73(11):7190-7.
Score: 0.063
-
Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells. FEMS Microbiol Lett. 2005 Mar 15; 244(2):373-7.
Score: 0.060
-
Synthesis, Characterization and Antimicrobial Activity of Trimethylantimony(V) Biscyanoximates, a New Family of Antimicrobials. Molecules. 2024 Dec 06; 29(23).
Score: 0.059